Heil, M. L., Decker, J. M., Sfakianos, J. N., Shaw, G. M., Hunter, E., & Derdeyn, C. A. (2004). Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside outside the Peptide Interaction Site. American Society for Microbiology.
Citación estilo ChicagoHeil, Marintha L., Julie M. Decker, Jeffrey N. Sfakianos, George M. Shaw, Eric Hunter, y Cynthia A. Derdeyn. Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside Outside the Peptide Interaction Site. American Society for Microbiology, 2004.
Cita MLAHeil, Marintha L., et al. Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside Outside the Peptide Interaction Site. American Society for Microbiology, 2004.